Your patients may be eligible to participate in the MDS clinical trial if they
a. Are 18 years of age or older
b. Have suspected or diagnosed MDS, preferably higher risk
c. Are not receiving corticosteroids >10 mg Prednisone/day or equivalent or immunosuppressants
To participate, patients will first be enrolled in PersImmune’s blood and marrow collection protocol https://clinicaltrials.gov/ct2/show/NCT03072498 to acquire the blood cells necessary to generate the immunized T cells.
During the time the product is generated, the patient may receive standard therapy for MDS. If the patient fails therapy, relapses, or declines to receive standard therapy, he or she will be evaluated for the clinical trial of experimental T cell infusion.
For more information: Download a more detailed letter to physicians about the trial and how to contact UC San Diego Moores Cancer Center in order to participate DOWNLOAD.
OR Search the UC San Diego Clinical Trials as follows:
a. Type the following URL https://health.ucsd.edu/clinicaltrials
b. Scroll down to the “Search Clinical Trials” button and click
c. Next to “SEARCH TRIALS” type in “MDS”
d. Click here: “Personalized Adoptive Cellular Therapy Targeting MDS Stem Cell Neoantigens (PACTN)” to find the contact information for Dr. Rafael Bejar and more information on how to participate.